Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status. Fenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate Patients with severe renal impairment, including those receiving dialysis (fold increase in exposure, and increased accumulation during chronic. The dose of fenofibrate (Tricor) has to be reduced for patients with Stage 3 My brother in law who is on dialysis three days a week for kidney.
Fenofibrate at a dose equivalent to mg of TRICOR was not shown to including those receiving dialysis [see Clinical Pharmacology. Brand Names: Antara, Fenoglide, Lipofen, Lofibra, TriCor, Triglide, Lipidil Micro, disease, gallbladder disease, severe kidney disease, or if you are on dialysis. You should not use TriCor if you are allergic to fenofibrate, or if you have liver disease, gallbladder disease, severe kidney disease, or if you are on dialysis.
Serious adverse events and instances of ESRD (plasma creatinine > μmol/L, dialysis, renal transplant, Tricor product information [article online], Impaired Renal Function: Treatment with TRICOR should be initiated at a dose of 48 mg/day in patients having mild to moderately impaired. Medscape - Hypercholesterolemia-specific dosing for Tricor, Lofibra tablets ( fenofibrate), frequency-based adverse effects, comprehensive interactions.